Parametric Portfolio Associates’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Parametric Portfolio Associates’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$660K	Sell	29,630 -10,629	-26%	-$271K	﹤0.01%	2957
2021 Q4	$1.76M	Buy	40,259 +2,592	+7%	+$104K	﹤0.01%	2511
2021 Q3	$1.25M	Buy	37,667 +2,890	+8%	+$87.9K	﹤0.01%	2692
2021 Q2	$957K	Buy	34,777 +817	+2%	+$17K	﹤0.01%	2791
2021 Q1	$682K	Buy	33,960 +4,517	+15%	+$132K	﹤0.01%	3339
2020 Q4	$971K	Sell	29,443 -12,741	-30%	-$339K	﹤0.01%	3070
2020 Q3	$759K	Buy	+42,184	New	+$764K	﹤0.01%	3073

Other funds holding INBX

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Parametric Portfolio Associates's INBX Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Inhibrx, Inc. Common Stock (INBX) stake by 26% in Q1 2022, selling an estimated $271K and leaving 29,630 shares worth $660K. The position accounts for ﹤0.01% of the portfolio, ranked #2957.

Parametric Portfolio Associates first reported a position in INBX in Q3 2020 and has held it in 7 quarters since. The position peaked at $1.76M in Q4 2021. 99 funds tracked by Wall St. Rank hold INBX as of Q1 2022.

Parametric Portfolio Associates held 29,630 shares of Inhibrx, Inc. Common Stock worth $660K as of Q1 2022.
Parametric Portfolio Associates sold 10,629 Inhibrx, Inc. Common Stock shares in Q1 2022, an estimated $271K.
Inhibrx, Inc. Common Stock made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2957 holding.
Parametric Portfolio Associates first reported a position in Inhibrx, Inc. Common Stock in Q3 2020 and has held it in 7 quarters since.
Parametric Portfolio Associates's Inhibrx, Inc. Common Stock position peaked at $1.76M in Q4 2021.
99 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.